Up to 40% of annual premature deaths in the US 'are preventable'
5/02/2014
Between 20-40% of deaths below the age of 80 - from the five leading causes of death in the US - are due to modifiable risk factors that could be prevented, claim the CDC.
To solve a puzzle, you need to recognize shapes, patterns and a particular kind of order.
Hematology-2014, September 29-October 01, 2014, Baltimore
5/01/2014
Novel therapeutics for blood disorders: A New hope for Patients suffering from severe Blood DisordersHematology-2014 is an endeavor from OMICS Group to identify the novel therapeutics for...
New model can predict therapy outcomes in prostate cancer with bone metastasis
5/01/2014
A new computational model that simulates bone metastasis of prostate cancer has the potential to rapidly assess experimental therapy outcomes and help develop personalized medicine for patients...
OncoGenex Pharmaceuticals, Inc. has announced results from the Phase 3 SYNERGY trial.
Research letter examines UV nail salon lamps and risk of skin cancer
5/01/2014
Using higher-wattage ultra violet (UV) lamps at nail salons to dry and cure polish was associated with more UV-A radiation being emitted, but the brief exposure after a manicure would require...
FDA approves Zykadia for late-stage lung cancer
5/01/2014
The U.S. Food and Drug Administration today granted accelerated approval to Zykadia (ceritinib) for patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC).
1st published data for VolitionRx's diagnostic blood tests for bowel cancer
5/01/2014
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, has announced that preliminary data from University Hospital Bonn...
Depression is detectable in the blood
5/01/2014
Researchers at the MedUni Vienna have demonstrated the possibility of using a blood test to detect depression.
Work in mice advances potential for nanoparticles to treat brain cancer
5/01/2014
Working together, Johns Hopkins biomedical engineers and neurosurgeons report that they have created tiny, biodegradable "nanoparticles" able to carry DNA to brain cancer cells in mice.